Peptide YY (13-36) (canine, mouse, porcine, rat) is a peptide fragment derived from the proline-rich peptide hormone peptide YY, corresponding to the C-terminal region spanning residues 13-36 and produced as a sequence-defined, peptide-based research reagent rather than a free amino acid. The molecule contains multiple peptide amide linkages with a C-terminal carboxyl group and an N-terminal amino group at the fragment boundaries, and its side chains reflect the native residue composition of the specified species variant, enabling physicochemical behavior consistent with short peptide fragments. In biochemical and chemical biology workflows, this fragment is used as a substrate or reference material for receptor-binding and structure-activity studies, for analytical method development such as chromatographic or mass spectrometric characterization of peptide standards, and for comparative experiments across species-specific sequence variants.
CAT No: CP04904
CAS No:86895-09-2
Synonyms/Alias:PeptideYY(13-36)(canine,mouse,porcine,rat);86895-09-2
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
5. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.